Welcome to our dedicated page for Enhabit SEC filings (Ticker: EHAB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Enhabit, Inc. filings document formal disclosures for a public home health and hospice care provider. Recent reports include 8-K material-event disclosures, Regulation FD materials, operating and financial results, risk-factor updates, shareholder voting matters and capital-structure information.
The company’s SEC record also covers material definitive agreements, including credit facilities and related debt terms, governance matters such as officer transitions, and litigation-related disclosures involving claims connected to its home health and hospice business history. These filings frame Enhabit’s regulatory reporting around healthcare operations, financing arrangements, corporate governance and stockholder matters.
Hoeflinger Erin reported acquisition or exercise transactions in this Form 4 filing.
Enhabit, Inc. director Erin Hoeflinger received an equity-based compensation grant in the form of 1,698 deferred stock units of common stock. The units were credited at a reference price of $13.99 per share in lieu of a cash retainer fee under the Enhabit, Inc. Deferred Director Compensation Plan.
Following this grant, Hoeflinger directly holds 80,405 shares of Enhabit common stock. This is a routine director compensation award rather than an open-market share purchase.
Enhabit, Inc. director Charles M. Elson received an equity grant valued in stock rather than cash. On this Form 4, he acquired 1,340 shares of Common Stock-equivalent deferred stock units at $13.99 per share in lieu of a cash retainer fee under the Enhabit, Inc. Deferred Director Compensation Plan.
Following this award, Elson directly holds 80,638 shares of Enhabit common stock, reflecting his updated post-grant position as reported in the filing.
Enhabit, Inc. director Jeffrey Bolton acquired 2,680 shares of common stock-valued deferred stock units at $13.99 per unit as compensation. The units were received in lieu of a cash retainer fee under the Enhabit, Inc. Deferred Director Compensation Plan. Following this grant, Bolton directly holds 139,682 common shares-equivalent units.
Enhabit, Inc. Schedule 13G/A amendment reports that the group of related reporting persons led by 8 Knots Management / Scott Green holds 0 shares of Enhabit Common Stock and therefore no longer beneficially owns more than 5% of the class. The filing cites 50,723,245 shares outstanding as disclosed on the Form 10-K dated March 5, 2026, and is signed April 9, 2026 as an exit filing.
Enhabit, Inc. is asking shareholders to approve a merger in which Anchor Parent, LLC (affiliated with Kinderhook) will acquire Enhabit and convert each outstanding share into $13.80 in cash (the "Per Share Amount"). The Board unanimously recommends approval and Goldman Sachs delivered a fairness opinion dated that the consideration was fair. The Merger Consideration represents an approximate 33.8% premium to the 60‑day VWAP through February 20, 2026. If approved and closed, Enhabit common stock will be delisted and deregistered, equity awards will vest or be cashed out per the Merger Agreement, and holders who do not vote in favor may seek appraisal under Delaware law. The transaction is supported by debt commitments and a $688 million equity commitment from Kinderhook funds; Closing is subject to regulatory clearances and customary conditions.
Enhabit Inc amendment reports that The Vanguard Group beneficially owns 0 shares of Common Stock, representing 0% of the class. The filing explains an internal realignment effective January 12, 2026 and states reporting is now disaggregated in accordance with SEC Release No. 34-39538 (January 12, 1998).
The filing is signed by Ashley Grim, Head of Global Fund Administration, on 03/26/2026. It lists Vanguard's address and confirms no single other person's interest exceeds 5%.
Enhabit, Inc. reported that Chief Accounting Officer Collin McQuiddy sold 1,403 shares of common stock in an open-market transaction on March 11, 2026 at $13.61 per share. After this sale, he directly holds 3,991 shares of Enhabit common stock.
Enhabit, Inc. executive Julie Diane Jolley, EVP of Home Health Operations, reported open-market sales of company common stock. She sold a total of 5,586 shares in two transactions of 2,793 shares each on March 9 and 10, 2026, at a price of $13.63 per share. After these sales, she directly holds 137,130 Enhabit common shares.
Marion Tanya Renee reported acquisition or exercise transactions in this Form 4 filing.
Enhabit, Inc. Chief Human Resources Officer Tanya Renee Marion reported an amended insider transaction reflecting a previously omitted stock award. On March 6, 2026, she received a grant of 10,287 shares of common stock at $13.61 per share, increasing her direct holdings to 103,339 shares. The filing also notes 1,712 shares of common stock held indirectly by her spouse. A footnote explains this award was left out of the original report due to a clerical error.
Solomon Ryan reported acquisition or exercise transactions in this Form 4 filing.
Enhabit, Inc. Chief Financial Officer Ryan Solomon reported an amended insider transaction reflecting a prior equity award. On this Form 4/A, he received a grant of 18,370 shares of common stock at $13.61 per share as compensation. After this award, he directly owns 193,911 common shares. A footnote explains the grant had been omitted from the original filing due to a clerical error, and the amendment brings his reported holdings up to date.